SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
S.1089 "Restoring Access to Medication Act of 2019" provision to repeal tax provisions to prevent HSA eligibility for OTC medicines.
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
Copyright/Patent/Trademark CPT
Issues related to Compulsory Licensing; issues related to drug patents; and issues related to S. 1416 "Affordable Prescription for Patients Act of 2019".
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| JUAN MACHADO | — |
| AMY L REDL | — |
| ELIZABETH STOWER | — |
Budget/Appropriations BUD
Biodefense appropriation issues related to Biomedical Advanced Research and Development Authority (BARDA)
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY L REDL | — |
Health Issues HCR
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing; issues related to seasonal influenza vaccination; issues related to Drug Importation;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to Arbitration; issues related to H.R. 2087 "Drug Price Transparency Act"; issues related to S.977 "Medicare Drug Price Negotiation Act"; issues related to S.1379 " Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019"; and issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019:.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| JUAN MACHADO | — |
| KATIE OPPENHEIM | — |
| AMY L REDL | — |
| ELIZABETH STOWER | — |
Torts TOR
Issues related to S.340 "CREATES Act of 2019"; and issues related to HR 3199 "Terminating the Extension of Rights Misappropriated Act of 2019"
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| KATIE OPPENHEIM | — |
| AMY L REDL | — |
Medicare/Medicaid MMM
Issues related to S.99 "Medicare Drug Price Negotiation Act"; issues related to blended ASP authorized generics; issues related to Medicaid AMP CAP; and issues related to international price index.
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| JUAN MACHADO | — |
| AMY L REDL | — |
| ELIZABETH STOWER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.